David Rose is a successful entrepreneur with experience in all phases of business creation, organizational growth, and management with demonstrated talent in business development and relationship management. He is the Co-Founder of Aduro Biotech, which went public in 2015 (NASD:ADRO) and is now Chinook Therapeutics (KDNY). David is also General Partner of KG Partners LP, a real estate investment, property management, and development company where he has been responsible for investment, debt, and liquidation decisions. He has experience in the non-profit sector, where he was Executive Director of Small Schools for Equity. David is looking forward to transitioning out of the private sector to address challenges that face the Bay Area and the world!